[Obesity associated metabolic impairment is evident at early ages: Spanish collaborative study]

Gabriel Á Martos-Moreno1, Mercedes Gil-Campos2, Gloria Bueno3

  • 1Servicio de Endocrinología, Hospital Infantil Universitario Niño Jesús. Instituto de Investigación La Princesa. Universidad Autónoma de Madrid. CIBERobn, ISCIII.. gabrielangelmartos@yahoo.es.

Nutricion Hospitalaria
|October 23, 2014
PubMed

Insights

Metabolic abnormalities are common in Spanish children with early-onset obesity, even before age 10. These health issues are present even in very-early-onset obesity cases, highlighting the need for early intervention.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Health
  • Obesity Research

Background:

  • Childhood obesity is a growing concern with significant health implications.
  • Early-onset obesity presents unique challenges in diagnosis and management.
  • Metabolic syndrome (MS) criteria may not fully capture metabolic derangements in younger children.

Purpose of the Study:

  • To describe demographic, anthropometric, and metabolic characteristics of children with early-onset (<10 years) and very-early-onset (<5 years) obesity.
  • To evaluate the diagnostic performance of different metabolic syndrome (MS) criteria in these pediatric populations.

Main Methods:

  • A multicenter, retrospective, case-control, cross-sectional study involving 10 Spanish Pediatric Endocrinology Units.
  • Studied 469 children with early-onset obesity, 30 with very-early-onset obesity, and 224 healthy controls.
  • Collected anthropometric data and analyzed carbohydrate metabolism and lipid profiles.

Main Results:

  • Metabolic alterations associated with obesity are prevalent in Spanish children, both independently and as part of MS.
  • Insulin resistance significantly increases the prevalence of detected metabolic abnormalities.
  • Metabolic abnormalities are present in a remarkable percentage of children even below the International Diabetes Federation (IDF) age criteria for MS, including those with very-early-onset obesity (<5 years).

Conclusions:

  • Metabolic alterations linked to obesity are present in Spanish children during infant-juvenile stages.
  • These abnormalities occur even at earlier ages than typically defined by MS criteria.
  • Early identification and intervention for metabolic derangements in pediatric obesity are crucial.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
5
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
6
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
317
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K